fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Breast cancer: Why metastasis spreads to the bone

Written by | 28 Apr 2022

When cancer cells break away from a primary tumor and migrate to other organs, this is called “metastatic cancer.” The organs affected by these metastases, however, depend in… read more.

Therapeutic target for aggressive blood cancer

Written by | 25 Apr 2022

A new study published today in the journal Genes & Development reveals a gene that normally suppresses the formation of tumours but is reprogrammed at the onset of acute promyelocytic… read more.

Novel combination treatment effective in recurrent ER-positive endometrial cancer

Written by | 20 Apr 2022

Researchers from a phase 2 study report that combination treatment with abemaciclib and letrozole shrinks or stabilizes tumors in a majority of subjects diagnosed with recurrent or persistent… read more.

How ovarian cancer defies immunotherapy

Written by | 12 Apr 2022

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators at La Jolla Institute for Immunology and… read more.

Researchers shorten manufacturing time for CAR T cell therapy

Written by | 1 Apr 2022

A new approach from Penn Medicine researchers could cut the time it takes to alter patients’ immune cells for infusion back into the body to find and attack… read more.

Potential therapy may boost chemoimmunotherapy response in bladder cancer

Written by | 30 Mar 2022

Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancerinvestigators. The… read more.

Half of all women experience false positive mammograms after 10 years of annual screening

Written by | 28 Mar 2022

A study led by UC Davis Health has found that half of all women will experience at least one false positive mammogram over a decade of annual breast… read more.

CHMP recommends Opdivo + Yervoy for first line treatment of metastatic esophageal squamous cell carcinoma – BMS

Written by | 27 Mar 2022

Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Opdivo (nivolumab) plus Yervoy… read more.

Researchers use ultrasound to predict ovarian cancer

Written by | 25 Mar 2022

The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery, according to a new study published in… read more.

Mayo Clinic discovery in bone marrow cancer points to potential drug targets

Written by | 20 Mar 2022

New research from Mayo Clinic’s Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow — have distinctive epigenetic changes… read more.

AI provides accurate breast density classification

Written by | 19 Mar 2022

An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a study in Radiology: Artificial Intelligence. Breast density reflects the amount of fibroglandular… read more.

Endometriosis and ovarian cancer genetically tied

Written by | 17 Mar 2022

University of Queensland researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.